Adendra Therapeutics

About:

Adendra Therapeutics wants to use new insights into dendritic cell biology to develop a novel type of immunotherapy.

Website: https://adendratx.com/

Top Investors: Apple Tree Partners

Description:

Adendra is an emerging biotechnology company building on new insights into dendritic cell biology to discover and develop new small molecule and biologic medicines for the treatment of a wide range of cancers and autoimmune diseases.

Total Funding Amount:

40M GBP

Headquarters Location:

London, England, United Kingdom

Founded Date:

2021-01-01

Founders:

Caetano Reis e Sousa, Raj Mehta

Number of Employees:

1-10

Last Funding Date:

2021-12-07

IPO Status:

Private

Industries:

© 2025 bioDAO.ai